Related Experiment Video
Updated: Mar 31, 2026
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
[Early results of endoscopic sleeve gastroplasty in a Hungarian patient cohort]
Árpád Szántó1, Áron Endre Vincze2, Zsombor Márton3
11 Tolna Vármegyei Balassa János Kórház, Aneszteziológiai és Intenzív Terápiás Osztály Szekszárd Magyarország.
Introduction:
Obesity is a major public health problem worldwide, including in Hungary, and is associated with increased cardiovascular and metabolic risk. Bariatric interventions represent effective treatment options; however, due to the invasiveness and irreversibility of surgical techniques, there is a growing demand for minimally invasive alternatives.
Objective:
The aim of this study was to describe the preoperative anthropometric characteristics of patients undergoing endoscopic sleeve gastroplasty (ESG) and to evaluate the short-term safety and effectiveness of the procedure.
Method:
In this prospective observational study, 193 patients who underwent ESG were included. Preoperative anthropometric parameters as well as changes in body weight and body mass index (BMI) were assessed at 3, 6, 9, and 12 months after the intervention. Body fat percentage was estimated using the Deurenberg formula.
Results:
The mean age of the study population was 46.1 years, with a mean BMI of 39.1 kg/m². The estimated mean body fat percentage was 47.5%. Following ESG, BMI decreased to 87.8% of the baseline value at 3 months, 83.0% at 6 months, and 81.3% at 12 months. No surgical complications were observed.
Conclusion:
Endoscopic sleeve gastroplasty is a safe, minimally invasive procedure that results in clinically relevant short-term weight loss. Orv Hetil. 2026; 167(13): 512-516.
